Implementation and validation of face de‐identification (de‐facing) in ADNI4

Christopher G. Schwarz,Mark Choe,Stephanie Rossi,Sandhitsu R. Das,Ranjit Ittyerah,Evan Fletcher,Pauline Maillard,Baljeet Singh,Danielle J. Harvey,Ian B. Malone,Lloyd Prosser,Matthew L. Senjem,Leonard C. Matoush,Chadwick P. Ward,Carl M. Prakaashana,Susan M. Landau,Robert A. Koeppe,JiaQie Lee,Charles DeCarli,Michael W. Weiner,Clifford R. Jack,William J. Jagust,Paul A. Yushkevich,Duygu Tosun,for the Alzheimer's Disease Neuroimaging Initiative
DOI: https://doi.org/10.1002/alz.14303
2024-10-13
Alzheimer s & Dementia
Abstract:INTRODUCTION Recent technological advances have increased the risk that de‐identified brain images could be re‐identified from face imagery. The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a leading source of publicly available de‐identified brain imaging, who quickly acted to protect participants' privacy. METHODS An independent expert committee evaluated 11 face‐deidentification ("de‐facing") methods and selected four for formal testing. RESULTS Effects of de‐facing on brain measurements were comparable across methods and sufficiently small to recommend de‐facing in ADNI. The committee ultimately recommended mri_reface for advantages in reliability, and for some practical considerations. ADNI leadership approved the committee's recommendation, beginning in ADNI4. DISCUSSION ADNI4 de‐faces all applicable brain images before subsequent pre‐processing, analyses, and public release. Trained analysts inspect de‐faced images to confirm complete face removal and complete non‐modification of brain. This paper details the history of the algorithm selection process and extensive validation, then describes the production workflows for de‐facing in ADNI. Highlights ADNI is implementing "de‐facing" of MRI and PET beginning in ADNI4. "De‐facing" alters face imagery in brain images to help protect privacy. Four algorithms were extensively compared for ADNI and mri_reface was chosen. Validation confirms mri_reface is robust and effective for ADNI sequences. Validation confirms mri_reface negligibly affects ADNI brain measurements.
clinical neurology
What problem does this paper attempt to address?